Zhou, D.J., et al. 2020. Driving ability and safety in rheumatoid arthritis: A systematic review. Arthritis Care Res (Hoboken). https://doi.org/10.1002/acr.24137.
Zhao, S.S., H. Lyu, D.H. Solomon, and K. Yoshida. 2020. Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: Systematic review using a target trial emulation framework. Annals of the Rheumatic Diseases 79: 883–890. https://doi.org/10.1136/annrheumdis-2020-217200.
Zafari, P., et al. 2020. Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: A systematic review and meta-analysis of case-control studies. Clinical Rheumatology 39: 127–134. https://doi.org/10.1007/s10067-019-04713-z.
Wang, Z., Bao, H.W. and Y.A., Ji. 2020. systematic review and meta-analysis of rituximab combined with methotrexate versus methotrexate alone in the treatment of rheumatoid arthritis. Medicine (Baltimore) 99: e19193.https://doi.org/10.1097/MD.0000000000019193.
Zhang, L., P. Cai, and W. Zhu. 2020. Depression has an impact on disease activity and health-related quality of life in rheumatoid arthritis: A systematic review and meta-analysis. International Journal of Rheumatic Diseases 23: 285–293. https://doi.org/10.1111/1756-185X.13774.
Wang, H., X., Li, and G. Gong. 2020. Cardiovascular outcomes in patients with co-existing coronary artery disease and rheumatoid arthritis: A systematic review and meta-analysis. Medicine (Baltimore) 99: e19658. https://doi.org/10.1097/MD.0000000000019658.
Vasconcelos, L.B., M.T. Silva, and T.F. Galvao. 2020. Reduction of biologics in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology International. https://doi.org/10.1007/s00296-020-04651-z.
Silvagni, E., et al. 2020. One year in review 2020: Novelties in the treatment of rheumatoid arthritis. Clinical and Experimental Rheumatology 38: 181–194.
Dietze, A., B. Engesaeter, and K. Berg. 2005. Transgene delivery and gelonin cytotoxicity enhanced by photochemical internalization in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis patients. Photochemical & Photobiological Sciences 4: 341–347. https://doi.org/10.1039/b416521g.
Kraan, M.C., et al. 2004. T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis. Annals of the Rheumatic Diseases 63: 483–488. https://doi.org/10.1136/ard.2003.009225.
CAS Article PubMed PubMed Central Google Scholar
Zhai, K.F., et al. 2017. Protective effects of paeonol on inflammatory response in IL-1beta-induced human fibroblast-like synoviocytes and rheumatoid arthritis progression via modulating NF-kappaB pathway. Inflammopharmacology. https://doi.org/10.1007/s10787-017-0385-5.
Zhu, L., and L. Zhu. 2017. Sophocarpine suppress inflammatory response in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis. European Cytokine Network 28: 120–126. https://doi.org/10.1684/ecn.2017.0400.
CAS Article PubMed Google Scholar
Agonia, I., et al. 2020. IL-17, IL-21 and IL-22 polymorphisms in rheumatoid arthritis: A systematic review and meta-analysis. Cytokine 125: 154813. https://doi.org/10.1016/j.cyto.2019.154813.
CAS Article PubMed Google Scholar
Yang, P., et al. 2019. Th17 cell pathogenicity and plasticity in rheumatoid arthritis. Journal of Leukocyte Biology 106: 1233–1240. https://doi.org/10.1002/JLB.4RU0619-197R.
CAS Article PubMed Google Scholar
Mohammadi, F.S., et al. 2019. Are genetic variations in IL-21-IL-23R-IL-17A cytokine axis involved in a pathogenic pathway of rheumatoid arthritis? Bayesian hierarchical meta-analysis. Journal Cell Physiology 234: 17159–17171. https://doi.org/10.1002/jcp.28495.
Taams, L.S. 2020. Interleukin-17 in rheumatoid arthritis: trials and tribulations. The Journal of Experimental Medicine 217. https://doi.org/10.1084/jem.20192048.
van Hamburg, J.P., and S.W. Tas. 2018. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis. Journal of Autoimmunity 87: 69–81. https://doi.org/10.1016/j.jaut.2017.12.006.
CAS Article PubMed Google Scholar
Agarwal, S., R. Misra, and A. Aggarwal. 2010. Induction of metalloproteinases expression by TLR ligands in human fibroblast like synoviocytes from juvenile idiopathic arthritis patients. Indian Journal of Medical Research 131: 771–779.
Samarpita, S., R. Ganesan, and M. Rasool. 2020. Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis. Toxicology and Applied Pharmacology 391: 114917. https://doi.org/10.1016/j.taap.2020.114917.
CAS Article PubMed Google Scholar
Chen, S., et al. 2020. Interleukin 17A and IL-17F expression and functional responses in rheumatoid arthritis and peripheral spondyloarthritis. Journal of Rheumatology 47: 1606–1613. https://doi.org/10.3899/jrheum.190571.
CAS Article PubMed Google Scholar
Lee, S.Y., et al. 2014. Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes. Immunology 141: 353–361. https://doi.org/10.1111/imm.12196.
CAS Article PubMed PubMed Central Google Scholar
Lao, M., et al. 2016. Protein Inhibitor of activated STAT3 regulates migration, invasion, and activation of fibroblast-like synoviocytes in rheumatoid arthritis. The Journal of Immunology 196: 596–606. https://doi.org/10.4049/jimmunol.1403254.
CAS Article PubMed Google Scholar
Olesch, C., C. Ringel, B. Brune, and A. Weigert. 2017. Beyond immune cell migration: The emerging role of the sphingosine-1-phosphate receptor S1PR4 as a modulator of innate immune cell activation. Mediators of Inflammation 2017: 6059203. https://doi.org/10.1155/2017/6059203.
CAS Article PubMed PubMed Central Google Scholar
Xiong, Y., et al. 2019. CD4 T cell sphingosine 1-phosphate receptor (S1PR)1 and S1PR4 and endothelial S1PR2 regulate afferent lymphatic migration. Science Immunology 4. https://doi.org/10.1126/sciimmunol.aav1263.
Schuster, C., et al. 2020. S1PR4-dependent CCL2 production promotes macrophage recruitment in a murine psoriasis model. European Journal of Immunology 50: 839–845. https://doi.org/10.1002/eji.201948349.
CAS Article PubMed Google Scholar
Olesch, C., et al. 2020. S1PR4 ablation reduces tumor growth and improves chemotherapy via CD8+ T cell expansion. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI136928.
Article PubMed PubMed Central Google Scholar
Burg, N., J.E. Salmon, and T. Hla. 2022. Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases. Nature Reviews Rheumatology 18: 335–351. https://doi.org/10.1038/s41584-022-00784-6.
CAS Article PubMed Google Scholar
Wang, M., et al. 2021. Inhibition of sphingosine 1-phosphate (S1P) receptor 1/2/3 ameliorates biological dysfunction in rheumatoid arthritis fibroblast-like synoviocyte MH7A cells through Galphai/Galphas rebalancing. Clinical and Experimental Pharmacology and Physiology 48: 1080–1089. https://doi.org/10.1111/1440-1681.13460.
CAS Article PubMed Google Scholar
Kalden, J.R., and H. Schulze-Koops. 2017. Immunogenicity and loss of response to TNF inhibitors: Implications for rheumatoid arthritis treatment. Nature Reviews Rheumatology 13: 707–718. https://doi.org/10.1038/nrrheum.2017.187.
CAS Article PubMed Google Scholar
Bonelli, M., et al. 2019. IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes: JAKinibs suppress the interferon response in RA-FLSs. Experimental & Molecular Medicine 51: 75. https://doi.org/10.1038/s12276-019-0267-6.
Sun, M., et al. 2020. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis. Life Sciences 256: 117988. https://doi.org/10.1016/j.lfs.2020.117988.
CAS Article PubMed Google Scholar
Inoue, T., et al. 2019. Upregulation of sphingosine-1-phosphate receptor 3 on fibroblast-like synoviocytes is associated with the development of collagen-induced arthritis via increased interleukin-6 production. PLoS ONE 14: e0218090. https://doi.org/10.1371/journal.pone.0218090.
CAS Article PubMed PubMed Central Google Scholar
Perez-Jeldres, T., M. Alvarez-Lobos, and J. Rivera-Nieves. 2021. Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: Beyond multiple sclerosis. Drugs 81: 985–1002. https://doi.org/10.1007/s40265-021-01528-8.
CAS Article PubMed PubMed Central Google Scholar
Bigaud, M., et al. 2016. Pathophysiological consequences of a break in S1P1-dependent homeostasis of vascular permeability revealed by S1P1 competitive antagonism. PLoS ONE 11: e0168252. https://doi.org/10.1371/journal.pone.0168252.
CAS Article PubMed PubMed Central Google Scholar
Lee, C.F., et al. 2019. Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase. Oncogene 38: 5580–5598. https://doi.org/10.1038/s41388-019-0833-3.
CAS Article PubMed Google Scholar
Hong, C.H., et al. 2022. Sphingosine 1-phosphate receptor 4 promotes nonalcoholic steatohepatitis by activating NLRP3 inflammasome. Cellular and Molecular Gastroenterology and Hepatology 13: 925–947. https://doi.org/10.1016/j.jcmgh.2021.12.002.
Dillmann, C., J. Mora, C. Olesch, B. Brune, and A. Weigert. 2015. S1PR4 is required for plasmacytoid dendritic cell differentiation. Biological Chemistry 396: 775–782. https://doi.org/10.1515/hsz-2014-0271.
CAS Article PubMed Google Scholar
Suh, J.H., et al. 2018. Sphingosine-1-phosphate signaling and metabolism gene signature in pediatric inflammatory bowel disease: A matched-case control pilot study. Inflammatory Bowel Diseases 24: 1321–1334. https://doi.org/10.1093/ibd/izy007.
Article PubMed PubMed Central Google Scholar
Zhang, J., et al. 2019. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease. American Journal of Physiology. Lung Cellular and Molecular Physiology 316: L487–L497. https://doi.org/10.1152/ajplung.00301.2018.
留言 (0)